Ekso Bionics Holdings Inc (EKSO) Actualités

Ekso Bionics to Showcase Its Device Technology in ‘AI for Good’ Webinar on Tuesday, November 19

SAN RAFAEL, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference

SAN RAFAEL, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Ekso Bionics Announces Third Quarter 2024 Financial Results

SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...

Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024

SAN RAFAEL, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form EFFECT - Notice of Effectiveness

Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering

SAN RAFAEL, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal

- Company Launches EksoHealth Personal Program to Help Individuals Access Exoskeletons - SAN RAFAEL, Calif...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]